Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel

Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases.

Publication ,  Journal Article
Chaudhry, V; Cornblath, DR; Griffin, JW; O'Brien, R; Drachman, DB
Published in: Neurology
January 9, 2001

The authors report the use mycophenolate mofetil (MM) in the treatment of neuromuscular diseases. Thirty-eight patients (32 with MG, three with inflammatory myopathy, and three with chronic acquired demyelinating neuropathy) were treated with MM for an average duration of 12 months. All patients tolerated MM without major side effects. Twenty-four patients improved either in their functional status or in their ability to reduce corticosteroid dose. Mean time to improvement was 5 months.

Duke Scholars

Published In

Neurology

DOI

ISSN

0028-3878

Publication Date

January 9, 2001

Volume

56

Issue

1

Start / End Page

94 / 96

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Retrospective Studies
  • Neurology & Neurosurgery
  • Myositis
  • Mycophenolic Acid
  • Myasthenia Gravis
  • Middle Aged
  • Male
  • Immunosuppressive Agents
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chaudhry, V., Cornblath, D. R., Griffin, J. W., O’Brien, R., & Drachman, D. B. (2001). Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases. Neurology, 56(1), 94–96. https://doi.org/10.1212/wnl.56.1.94
Chaudhry, V., D. R. Cornblath, J. W. Griffin, R. O’Brien, and D. B. Drachman. “Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases.Neurology 56, no. 1 (January 9, 2001): 94–96. https://doi.org/10.1212/wnl.56.1.94.
Chaudhry V, Cornblath DR, Griffin JW, O’Brien R, Drachman DB. Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases. Neurology. 2001 Jan 9;56(1):94–6.
Chaudhry, V., et al. “Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases.Neurology, vol. 56, no. 1, Jan. 2001, pp. 94–96. Pubmed, doi:10.1212/wnl.56.1.94.
Chaudhry V, Cornblath DR, Griffin JW, O’Brien R, Drachman DB. Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases. Neurology. 2001 Jan 9;56(1):94–96.

Published In

Neurology

DOI

ISSN

0028-3878

Publication Date

January 9, 2001

Volume

56

Issue

1

Start / End Page

94 / 96

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Retrospective Studies
  • Neurology & Neurosurgery
  • Myositis
  • Mycophenolic Acid
  • Myasthenia Gravis
  • Middle Aged
  • Male
  • Immunosuppressive Agents
  • Humans